Suppliers / Centaur Pharmaceuticals

Centaur Pharmaceuticals

India 698 employees 3 duplicate records merged Updated 9 July 2026

Centaur Pharmaceuticals is an API and finished-dose manufacturer based in India. It holds 37 active US drug master files and 19 valid CEPs. Its filings concentrate with MINSA (CR), TMDA (TZ) and NAFDAC (NG). Its GMP standing is certified by EMA, US FDA and MHRA (UK), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 14 November 2025 as VAI. Customs aggregates show $51.6M of exports covering 2,077 molecules to 79 destinations in 2025.

37
active US DMFs
19
valid CEPs
5
registered plants 3 with an FDA FEI number
93
filings across 10 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
3 of 3 confirmed
Inspections
8 of 8 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 14 November 2025 VAI US FDA
  • 8 February 2023 OAI US FDA
  • 21 November 2022 OAI US FDA
  • 27 September 2019 VAI US FDA
  • 13 May 2019 NAI US FDA
  • 14 November 2016 VAI US FDA
  • 13 October 2016 NAI US FDA
  • 5 February 2015 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Mumbai, India Not on file
Pune, India 3008861619
Pernem, India 3013630102
Thane, India 3003973520
Karaswada Mapusa Goa, Nigeria Not on file

What they file, and where

Molecule Regulators Docs
Clobazam EDQM, SFDA (Saudi Arabia), US FDA 4
Metolazone EDQM, SFDA (Saudi Arabia), US FDA 4
Alprazolam EDQM, US FDA 3
Chlordiazepoxide EDQM, US FDA 3
Diazepam EDQM, US FDA 3
Timolol EDQM, SFDA (Saudi Arabia), US FDA 3
Zolpidem EDQM, US FDA 3
Zopiclone EDQM, US FDA 3
Brimonidine EDQM, US FDA 2
Chlorzoxazone US FDA 2
Show all 30 molecules on file
Clonazepam EDQM, US FDA 2
Eszopiclone SFDA (Saudi Arabia), US FDA 2
Fluphenazine US FDA 2
Levomilnacipran US FDA 2
Lorazepam EDQM, US FDA 2
Loxapine US FDA 2
Oxazepam EDQM, US FDA 2
Pindolol US FDA 2
Triazolam US FDA 2
Varenicline US FDA 2
Aripiprazole SFDA (Saudi Arabia) 1
Benzydamine EDQM 1
Benzydamine Hydrochlorid SFDA (Saudi Arabia) 1
Bromazepam EDQM 1
Fluphenazine Dihydrochloride EDQM 1
Linagliptin US FDA 1
Methylphenidate EDQM 1
Milnacipran US FDA 1
Nitrazepam EDQM 1
Nortriptyline EDQM 1

Also appears on these molecule pages

Acetazolamide finished dose Alprazolam API Amitriptyline finished dose Benserazide finished dose Brimonidine API Chlordiazepoxide API Chlorzoxazone API Clobazam API Clonazepam API Dextromethorphan finished dose Diazepam API Eszopiclone API
Show 24 more molecule pages
Fluphenazine API Gentamicin finished dose Levomilnacipran API Linagliptin API Lorazepam API Losartan finished dose Methylphenidate API Metolazone API Miconazole finished dose Milnacipran API Nortriptyline API Olopatadine finished dose Oxazepam API Oxymetazoline finished dose Pyridostigmine finished dose Rabeprazole finished dose Tetrabenazine API Tetracycline finished dose Timolol API Triamcinolone finished dose Varenicline API Zolpidem API Zopiclone API Aripiprazole API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 26 None
TMDA (TZ) 24 None
NAFDAC (NG) 16 1
DAV (Vietnam) 10 None
US FDA 6 1
BOMRA (BW) 4 None
EMA None 3
MHRA (UK) None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $9.5M 47
2025 Not reported $51.6M 79
2024 Not reported $30.4M 38
2023 Not reported $29.2M 41

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Centaur Pharmaceuticals

Does Centaur Pharmaceuticals hold a US DMF or a CEP?
Centaur Pharmaceuticals holds 37 active US drug master files and 19 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Centaur Pharmaceuticals FDA-registered?
3 sites operated by Centaur Pharmaceuticals carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Centaur Pharmaceuticals's last inspection go?
The most recent inspection on record closed on 14 November 2025 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 8 inspections are on file, of which 2 closed as OAI.
Where does Centaur Pharmaceuticals manufacture?
5 registered sites are on record, in India and Nigeria (Mumbai, Pune and Pernem among others). Every site is listed on this page with the register it came from.
What does Centaur Pharmaceuticals make?
30 molecules are on record against Centaur Pharmaceuticals, including Clobazam, Metolazone, Alprazolam and Chlordiazepoxide. Each links through to that molecule's full manufacturer list.
Which regulators recognise Centaur Pharmaceuticals's GMP?
Current GMP certificates are on record from EMA, US FDA, MHRA (UK) and NAFDAC (NG). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Centaur Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 1 active litigation matter is on record.
  • The most recent inspection outcome was VAI, on 14 November 2025.

Comparable suppliers

Cambrex Profarmaco Milano shares 8 molecules Matrix Pharmacorp shares 6 molecules F.I.S. Fabbrica Italiana Sintetici shares 6 molecules Lake Chemicals shares 6 molecules Dr Reddy's Laboratories shares 5 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts